A novel in vitro method for detecting undifferentiated human pluripotent stem cells as impurities in cell therapy products using a highly efficient culture system.
Innovative applications of cell therapy products (CTPs) derived from human pluripotent stem cells (hPSCs) in regenerative medicine are currently being developed. The presence of residual undifferentiated hPSCs in CTPs is a quality concern associated with tumorigencity. However, no simple in vitro me...
Guardado en:
Autores principales: | Keiko Tano, Satoshi Yasuda, Takuya Kuroda, Hirohisa Saito, Akihiro Umezawa, Yoji Sato |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4d820d1f61f44c70aa811667db34a3b0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
SALL3 expression balance underlies lineage biases in human induced pluripotent stem cell differentiation
por: Takuya Kuroda, et al.
Publicado: (2019) -
A selective cytotoxic adenovirus vector for concentration of pluripotent stem cells in human pluripotent stem cell-derived neural progenitor cells
por: Takamasa Hirai, et al.
Publicado: (2021) -
Salicylic diamines selectively eliminate residual undifferentiated cells from pluripotent stem cell-derived cardiomyocyte preparations
por: Karsten Burkert, et al.
Publicado: (2021) -
Identification of a Gene Encoding Slow Skeletal Muscle Troponin T as a Novel Marker for Immortalization of Retinal Pigment Epithelial Cells
por: Takuya Kuroda, et al.
Publicado: (2017) -
Elimination of undifferentiated human embryonic stem cells by cardiac glycosides
por: Yu-Tsen Lin, et al.
Publicado: (2017)